Lotus Pharm vs A Plus Biotech: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and A Plus Biotech (6918) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ A Plus Biotech

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYA Plus BiotechYoY
Oct 2026NT$2.13 billion-22.5%NT$81.1 million+29.8%
Sep 2026NT$2.77 billion+128.0%NT$79.5 million+13.4%
Aug 2026NT$2.11 billion+81.7%NT$76.6 million+11.0%
Jul 2026NT$2.49 billion+3.9%NT$86 million+20.1%
Jun 2026NT$3.4 billion+225.5%NT$79.2 million+4.2%
May 2026NT$2.32 billion+105.8%NT$78.9 million+27.2%
Apr 2026NT$3.09 billion+19.9%NT$84.9 million+11.9%
Mar 2026NT$4.35 billion+173.6%NT$73.8 million+16.2%
Feb 2026NT$2.24 billion+131.5%NT$74.2 million+6.5%
Jan 2026NT$2.05 billion-5.5%NT$71.4 million+13.0%
Dec 2025NT$2.44 billion+66.9%NT$72 million-1.5%
Nov 2025NT$1.06 billion-0.2%NT$80.4 million+25.1%
Oct 2025NT$2.75 billion+46.0%NT$62.5 million-7.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16